James D. Perkins – 20 April 2006
Paul Martin – 20 April 2006
Ajai Khanna, Marquis Hart, William L. Nyhan, Tarek Hassanein, Janice Panyard‐Davis, Bruce A. Barshop – 20 April 2006 – Liver transplantation has been reported in a few cases of maple syrup urine disease (MSUD), but is controversial. Many patients with approved indications for liver transplantation die before grafts are available.
Olivier Detry, Arnaud De Roover, Jean Delwaide, Robert F Dondelinger, Michel Meurisse, Pierre Honoré – 20 April 2006
Elisabetta Bugianesi, Giulio Marchesini – 20 April 2006
20 April 2006
Yasumasa Shirouzu, Mureo Kasahara, Yasutsugu Takada, Kaoru Taira, Seisuke Sakamoto, Kenji Uryuhara, Kohei Ogawa, Hiraku Doi, Hiroto Egawa, Koichi Tanaka – 20 April 2006 – The development of portopulmonary hypertension (PH) in a patient with end‐stage liver disease is related to high cardiac output and hyperdynamic circulation. However, PH following liver transplantation is not fully understood.
Maciej Wojcicki, Michael A. Silva, Paras Jethwa, Bridget Gunson, Simon R. Bramhall, David Mayer, John A.C. Buckels, Darius F. Mirza – 20 April 2006 – Biliary complications are common following split liver transplantation (SLT). We analyzed the incidence, treatment, and outcome of biliary complications following adult right lobe ex vivo SLT performed between November 1992 and January 2005. There were 72 patients, of which 70 were analyzed. Early postoperative deaths resulted in 2 being excluded from the analysis. There were 44 males (median age, 48 yr; range, 19–70 yr).
Anabel Brandoni, Silvina R. Villar, Juan C. Picena, Naohiko Anzai, Hitoshi Endou, Adriana M. Torres – 20 April 2006 – Renal function in the course of obstructive jaundice has been the subject of great interest; however, little is known about the expression of renal organic anion transporters. The objective of this work was to study, in rats with acute extrahepatic cholestasis, the cortical renal expression of the organic anion transporter 1 (OAT1) and the organic anion transporter 3 (OAT3), in association with the pharmacokinetics and renal excretion of furosemide (FS).
Cho‐Rok Jung, Jinsang Yoo, Ye Jin Jang, Sangsoo Kim, In‐Sun Chu, Young Il Yeom, Jong Young Choi, Dong‐Soo Im – 20 April 2006 – The pituitary tumor transforming (PTTG) gene family comprises PTTG1, 2, and 3. Forced expression of PTTG1 (securin) induces cellular transformation and promotes tumor development in animal models. PTTG1 is overexpressed in various human cancers. However, the expression and pathogenic implications of the PTTG gene family in hepatocellular carcinoma are largely unknown.